LABCORP NGS PANELS
Improving outcomes for patients with hematologic malignancies
Labcorp Myeloid NGS, Labcorp Lymphoid NGS and Labcorp Pan-Heme NGS are next generation sequencing (NGS) assays that evaluate clinically relevant genes to deliver diagnoses and risk stratification for complex hematologic malignancies.
Powering Better Decisions
Labcorp NGS Panels help identify gene alterations that have diagnostic, prognostic and therapeutic significance in patients with myeloid and lymphoid malignancies.
Labcorp Myeloid NGS Panel
To aid in diagnosis, prognostic risk assessment, and therapeutic selection in myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN)
Labcorp Lymphoid NGS Panel
To aid in diagnosis, prognostic risk assessment, and therapeutic selection in lymphoid malignancies, including lymphoblastic leukemias (B-ALL/T-ALL), CLL (chronic lymphocytic leukemia), DLBCL, mantle cell lymphoma, follicular lymphoma, T cell lymphoma, hairy cell leukemia and other lymphoma subtypes
Labcorp Pan-Heme NGS Panel
To aid in diagnosis, prognostic risk assessment, and therapeutic selection in various myeloid and lymphoid malignancies
Patient Reports: Concise, Comprehensive & Actionable
Comprehensive Quick-Read Results
Gain actionable insights at a glance with:
- Clinically significant results
- Therapy implications summary
- Personalized interpretation for each variant
THERAPEUTIC IMPLICATIONS
Start to formulate a plan with:
- FDA-approved therapies
- Possible drug resistance information
- Clinical trial information for each variant
PERSONALIZED INTERPRETATION:
Expand your patient’s options with:
- Diagnostic, prognostic and therapeutic significance
- Clinical trial matches for each variant
- Easy access to available trial information
| Sample requirements |
|---|
Please provide a clinical indication or related ICD-10 code on the test requisition form Specimen type: Bone marrow aspirate, peripheral blood and cell suspension from fresh tissue Volume: 3-5ml (whole blood); 1-2ml (bone marrow) Container: Lavender-top (EDTA) tube or green-top (heparin) tube |
| Turnaround time: 10-14 Days |
High Laboratory Quality Standards
- NYS CLEP approved
- CLIA and CAP accredited
Labcorp Broad National Coverage
- In-network with most major health plans